Retatrutide Is Not Yet Approved Explore Proven Medical Weight Loss Options Retatrutide is generating significant interest in the weight loss field, despite being not yet FDA approved
Contrave is another FDA-approved weight loss medication that takes a very different approach
If you are curious about supplements like berberine, our telehealth-first model allows you to discuss these interests with licensed providers who understand the nuances of GLP-1 therapy
Mouhammad ZA, Vohra R, Horwitz A, Thein AS, Rovelt J, Cvenkel B, Williams PA, Azuara-Blanco A, Kolko M (2022) Glucagon-Like Peptide 1 Receptor Agonists -Potential Game Changers in the Treatment of Glaucoma
Step 2 Telehealth Review Process After receiving the data provided in the questionnaire, the data will go through a review process by our specialists who will determine whether or not you are eligible to comply with the treatment
Saxenda (liraglutide) Saxenda is a GLP-1 medication appropriate for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, type 2 diabetes, or high cholesterol or triglycerides It is also approved for children ages 12 and above who weigh more than 132 pounds and are considered obese
